1. Home
  2. LIXT vs ILAG Comparison

LIXT vs ILAG Comparison

Compare LIXT & ILAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIXT
  • ILAG
  • Stock Information
  • Founded
  • LIXT 2005
  • ILAG 1981
  • Country
  • LIXT United States
  • ILAG Hong Kong
  • Employees
  • LIXT N/A
  • ILAG N/A
  • Industry
  • LIXT Biotechnology: Pharmaceutical Preparations
  • ILAG Office Equipment/Supplies/Services
  • Sector
  • LIXT Health Care
  • ILAG Consumer Discretionary
  • Exchange
  • LIXT Nasdaq
  • ILAG Nasdaq
  • Market Cap
  • LIXT 12.4M
  • ILAG 10.7M
  • IPO Year
  • LIXT N/A
  • ILAG 2022
  • Fundamental
  • Price
  • LIXT $4.85
  • ILAG $0.51
  • Analyst Decision
  • LIXT
  • ILAG
  • Analyst Count
  • LIXT 0
  • ILAG 0
  • Target Price
  • LIXT N/A
  • ILAG N/A
  • AVG Volume (30 Days)
  • LIXT 193.9K
  • ILAG 250.6K
  • Earning Date
  • LIXT 08-07-2025
  • ILAG 08-19-2025
  • Dividend Yield
  • LIXT N/A
  • ILAG N/A
  • EPS Growth
  • LIXT N/A
  • ILAG N/A
  • EPS
  • LIXT N/A
  • ILAG N/A
  • Revenue
  • LIXT N/A
  • ILAG $7,506,551.00
  • Revenue This Year
  • LIXT N/A
  • ILAG N/A
  • Revenue Next Year
  • LIXT N/A
  • ILAG N/A
  • P/E Ratio
  • LIXT N/A
  • ILAG N/A
  • Revenue Growth
  • LIXT N/A
  • ILAG 16.50
  • 52 Week Low
  • LIXT $0.64
  • ILAG $0.34
  • 52 Week High
  • LIXT $5.14
  • ILAG $1.35
  • Technical
  • Relative Strength Index (RSI)
  • LIXT 64.92
  • ILAG 52.49
  • Support Level
  • LIXT $4.20
  • ILAG $0.49
  • Resistance Level
  • LIXT $5.06
  • ILAG $0.59
  • Average True Range (ATR)
  • LIXT 0.44
  • ILAG 0.06
  • MACD
  • LIXT -0.02
  • ILAG 0.00
  • Stochastic Oscillator
  • LIXT 80.79
  • ILAG 44.83

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

About ILAG Intelligent Living Application Group Inc.

Intelligent Living Application Group Inc focuses on designing and producing affordable, high-quality locksets and smart security systems. The company offers high-quality mechanical locksets and smart locks to its customers. Its product portfolio comprises various ODM indoor and outdoor locksets, such as deadbolts, entry locksets, privacy locksets, passage locksets, and storeroom locks, which are marketed through brands like Kambo and Bamberg. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada.

Share on Social Networks: